treatment is about £400 a year, and to this must be added the cost of doing at least two cholecystograms. It is more difficult to place a precise cost on a cholecystectomy if this includes the time off work during the postoperative and convalescent period. Properly prosecuted, a cholecystectomy is a curative operation with a mortality rate of under 1 " ; but the mortality rate may be above 5 O when complications are present, and it is in just such conditions that dissolution treatment is inadvisable. Medical treatment is recommended for a selected group of patients; surgical treatment may be offered to virtually all patients, though there is an increased risk in some. The aged patient and those with medical disorders that carry an increased operative risk are the group to whom drugs might be offered.
Common bile duct stones
The growing skill with endoscopic retrograde cholangiography and sphincterotomy and the introduction of Dormia basket removal through the T-tube tract are tending to replace the in situ dissolution of retained common bile duct stones. If dissolution is contemplated the agent of choice is the medium chain fatty acid mono-octanoin (glyceryl-l-mono-octanoate) that is instilled continuously into the bile duct at 2-4 ml/h. Infusion at this rate reduces the frequency of adverse effects such as nausea, vomiting, abdominal pain, and diarrhoea. Mono-octanoin may be used only for cholesterol stones and is generally successful within one to three weeks.
Conclusions
The treatment of choice for gall stones remains cholecystectomy. At present radiological monitoring of patients under treatment is required, but there is no reason why, given adequate access to appropriate facilities, bile acid treatment should not be given by general practitioners. Unfortunately, the introduction of drugs to dissolve gall stones has been seen as a threat by many surgeons who have eschewed them as a therapeutic option. Medical dissolution should take its place with surgical intervention in managing gall stone disease. Properly used in correctly selected patients, bile acid treatment has much to offer. On the grounds that shielding an infant's immature gastrointestinal tract from cows' milk for the early months of life is believed to protect the infant from developing an allergy, is there any evidence that a similarly immature respiratory tract should be shielded from other allergens such as pollen and house dust in so far as this is possible ? There is considerable controversy over the suggestion that allergy may be prevented by dietary manipulations. Atopic individuals sometimes have a temporary defect of immune function in early infancy, during which period they can become sensitised. Matthew et all studied a group of infants born to allergic parents. Those mothers who had elected to breast feed were advised to follow a regimen including exclusive breast feeding from birth to 3 months and only selective weaning from 3 to 6 months. The mothers were also recommended to try to eliminate house dust mites and were selected only if they did not own pets. This treatment was compared with a non-treatment group of infants who were bottle fed, and their parents were given no advice on avoiding environmental allergens. When reviewed at 1 year, significantly more of the non-treatment group developed eczema compared with the treatment group. The predominant factor influencing this was assumed to be the breast feeding. Other investigations, however, have indicated that dietary manipulations in infancy have, if anything, only a small effect, and some have suggested that they merely postpone the development of allergy or have no effect whatsoever. I believe that the fundamental difference between the studies was that Matthew et all used measures to avoid additional environmental inhaling allergens. Protection from common inhalant allergens may therefore be more important than avoidance of food allergens. This impression is supported by the observation that there is a variation in the month of birth among patients with sensitivities to allergens. More asthmatic children with an allergy to house dust mite are born in the months from September to December, at a time when mite frequency is at its highest in household dust.2 Recently, a group from Finland have estimated that the incidence of allergy to birch pollen might be reduced by 280% if susceptible children were not born in the two months before the pollen season.3 Thus the answer to the question
